Maze Therapeutics, Inc. (MAZE)

Maze Therapeutics Statistics

Total Valuation

MAZE has a market cap or net worth of $368.32 million. The enterprise value is $198.14 million.

Market Cap	368.32M
Enterprise Value	198.14M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

MAZE has 43.80 million shares outstanding. The number of shares has increased by 19.33% in one year.

Current Share Class	43.80M
Shares Outstanding	43.80M
Shares Change (YoY)	+19.33%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	1.48%
Owned by Institutions (%)	4.86%
Float	18.43M

Valuation Ratios

The trailing PE ratio is 6.73.

PE Ratio	6.73
Forward PE	n/a
PS Ratio	0.12
Forward PS	n/a
PB Ratio	1.87
P/TBV Ratio	n/a
P/FCF Ratio	4.92
P/OCF Ratio	4.85
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 3.25, with an EV/FCF ratio of 2.65.

EV / Earnings	58.19
EV / Sales	1.18
EV / EBITDA	3.25
EV / EBIT	3.44
EV / FCF	2.65

Financial Position

The company has a current ratio of 9.76, with a Debt / Equity ratio of 0.14.

Current Ratio	9.76
Quick Ratio	9.52
Debt / Equity	0.14
Debt / EBITDA	0.40
Debt / FCF	0.36
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 50.47% and return on invested capital (ROIC) is 25.42%.

Return on Equity (ROE)	50.47%
Return on Assets (ROA)	23.07%
Return on Invested Capital (ROIC)	25.42%
Return on Capital Employed (ROCE)	26.19%
Revenue Per Employee	$1.34M
Profits Per Employee	$27,240
Employee Count	125
Asset Turnover	1.07
Inventory Turnover	n/a

Taxes

In the past 12 months, MAZE has paid $1.17 million in taxes.

Income Tax	1.17M
Effective Tax Rate	2.19%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	10.97
200-Day Moving Average	n/a
Relative Strength Index (RSI)	38.25
Average Volume (20 Days)	356,961

Short Selling Information

The latest short interest is 2.68 million, so 6.13% of the outstanding shares have been sold short.

Short Interest	2.68M
Short Previous Month	1.84M
Short % of Shares Out	6.13%
Short % of Float	14.56%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MAZE had revenue of $167.50 million and earned $3.41 million in profits. Earnings per share was $1.25.

Revenue	167.50M
Gross Profit	167.50M
Operating Income	57.59M
Pretax Income	-16.82M
Net Income	3.41M
EBITDA	60.88M
EBIT	57.59M
Earnings Per Share (EPS)	$1.25

Balance Sheet

The company has $196.81 million in cash and $26.63 million in debt, giving a net cash position of $170.18 million or $3.89 per share.

Cash & Cash Equivalents	196.81M
Total Debt	26.63M
Net Cash	170.18M
Net Cash Per Share	$3.89
Equity (Book Value)	196.90M
Book Value Per Share	-127.72
Working Capital	181.00M

Cash Flow

In the last 12 months, operating cash flow was $75.95 million and capital expenditures -$1.15 million, giving a free cash flow of $74.81 million.

Operating Cash Flow	75.95M
Capital Expenditures	-1.15M
Free Cash Flow	74.81M
FCF Per Share	$1.71

Margins

Gross margin is 100.00%, with operating and profit margins of 34.38% and 31.18%.

Gross Margin	100.00%
Operating Margin	34.38%
Pretax Margin	31.88%
Profit Margin	31.18%
EBITDA Margin	36.35%
EBIT Margin	34.38%
FCF Margin	44.66%

Dividends & Yields

MAZE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.33%
Shareholder Yield	n/a
Earnings Yield	0.92%
FCF Yield	20.31%

Analyst Forecast

The average price target for MAZE is $25.67, which is 207.06% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.67
Price Target Difference	207.06%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MAZE has an Altman Z-Score of 0.3 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.3
Piotroski F-Score	5